Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenophosphate synthetase 1 (SEPHS1) is an ATP-dependent enzyme that synthesizes selenophosphate from selenide and ATP, a crucial step in selenium metabolism[2][5][7]. Selenophosphate generated by SEPHS1 serves as the selenium donor for synthesis of selenocysteine, which is incorporated into selenoproteins—key regulators of redox balance and oxidative stress resilience[1][2][5]. SEPHS1 belongs to the transferase enzyme family, specifically dikinases (EC 2.7.9.3), and is implicated in biosynthetic and stress-response cellular pathways[2]. Deficiency or downregulation of SEPHS1 impairs selenoprotein biosynthesis, disrupts redox homeostasis, elevates reactive oxygen species, and accelerates cellular senescence, contributing to conditions like osteoarthritis[1][4]. Experimental evidence also links SEPHS1 to cancer progression, notably hepatocellular carcinoma cell invasion[4]. Systemic loss results in embryonic lethality in mice, underlining its fundamental physiological importance[1]. Therapeutic modulation is complicated by its vital metabolic role, and no direct drugs are clinically approved. SEPHS1, alongside its dependent selenoproteins, may serve as a biomarker for selenium status, redox stress, and disease susceptibility[1][4][5].
Acts as a ROS scavenger, mitigating the effects of SEPHS1 deficiency on oxidative stress and cellular senescence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenophosphate synthetase 1 (SEPHS1).